Connor Clark & Lunn Investment Management Ltd. trimmed its position in shares of Nu Skin Enterprises, Inc. (NYSE:NUS – Free Report) by 1.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 268,806 shares of the company’s stock after selling 3,079 shares during the period. Connor Clark & Lunn Investment Management Ltd.’s holdings in Nu Skin Enterprises were worth $1,852,000 as of its most recent SEC filing.
Several other hedge funds have also modified their holdings of the stock. Geode Capital Management LLC grew its holdings in shares of Nu Skin Enterprises by 1.1% during the third quarter. Geode Capital Management LLC now owns 1,130,487 shares of the company’s stock worth $8,333,000 after purchasing an additional 11,838 shares during the last quarter. Jane Street Group LLC lifted its position in shares of Nu Skin Enterprises by 358.4% during the 3rd quarter. Jane Street Group LLC now owns 924,993 shares of the company’s stock valued at $6,817,000 after acquiring an additional 723,220 shares during the period. Bank of New York Mellon Corp lifted its position in shares of Nu Skin Enterprises by 18.5% during the 4th quarter. Bank of New York Mellon Corp now owns 613,330 shares of the company’s stock valued at $4,226,000 after acquiring an additional 95,938 shares during the period. Hotchkis & Wiley Capital Management LLC raised its position in shares of Nu Skin Enterprises by 27.7% during the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 603,555 shares of the company’s stock worth $4,448,000 after purchasing an additional 130,980 shares during the last quarter. Finally, Prescott Group Capital Management L.L.C. raised its position in shares of Nu Skin Enterprises by 3.2% during the 4th quarter. Prescott Group Capital Management L.L.C. now owns 574,636 shares of the company’s stock worth $3,959,000 after purchasing an additional 17,623 shares during the last quarter. 82.84% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several analysts have commented on the stock. StockNews.com raised shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research note on Tuesday, February 25th. DA Davidson decreased their price target on shares of Nu Skin Enterprises from $11.00 to $7.00 and set a “neutral” rating for the company in a research report on Friday, December 20th.
Nu Skin Enterprises Price Performance
NUS opened at $8.03 on Wednesday. The firm has a market cap of $399.47 million, a price-to-earnings ratio of -2.72 and a beta of 1.06. Nu Skin Enterprises, Inc. has a fifty-two week low of $5.95 and a fifty-two week high of $14.04. The company’s 50-day moving average price is $7.25 and its 200 day moving average price is $7.11. The company has a quick ratio of 1.17, a current ratio of 1.82 and a debt-to-equity ratio of 0.56.
Nu Skin Enterprises (NYSE:NUS – Get Free Report) last posted its earnings results on Thursday, February 13th. The company reported $0.38 EPS for the quarter, topping the consensus estimate of $0.24 by $0.14. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%. The firm had revenue of $445.55 million during the quarter, compared to analysts’ expectations of $441.10 million. As a group, sell-side analysts expect that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current year.
Nu Skin Enterprises Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 5th. Investors of record on Monday, February 24th were paid a dividend of $0.06 per share. This represents a $0.24 annualized dividend and a yield of 2.99%. The ex-dividend date of this dividend was Monday, February 24th. Nu Skin Enterprises’s dividend payout ratio is presently -8.14%.
Nu Skin Enterprises Profile
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
See Also
- Five stocks we like better than Nu Skin Enterprises
- Following Congress Stock Trades
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- 3 Warren Buffett Stocks to Buy Now
- 3 Must-Own Stocks to Build Wealth This Decade
- Retail Stocks Investing, Explained
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS – Free Report).
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.